March 12, 2018
Altimmune Announces Pre-Clinical Data From its SparVax-L Anthrax Vaccine Program
Media
March 12, 2018
Wilson Therapeutics announces agenda for Capital Markets Day on 21 March 2018
March 07, 2018
Strongbridge Biopharma Investor and Analyst Day – Save the Date
March 07, 2018
Approval to launch the Phase I Study of repeated and increasing doses to assess CER-209 in NASH/NAFLD
March 07, 2018
NEXSTIM PLC PUBLISHES 2017 ANNUAL REPORT
March 06, 2018
Strongbridge Biopharma plc to Present at the Cowen and Company 38th Annual Healthcare Conference and the Oppenheimer 28th Annual Healthcare Conference
March 06, 2018
Wilson Therapeutics to Present at Upcoming Investor Conferences
March 05, 2018
Strongbridge Biopharma plc to Present KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis Data at the 2018 American Academy of Neurology Annual Meeting
February 28, 2018
Nexstim Financial Statements Release 2017
February 27, 2018
Nordic Nanovector ASA – Results for the Fourth Quarter and Full Year 2017: Solid performance through 2017, moving forward with pivotal trial